Lubiprostone
Product Images NDC 42291-475

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 42291-475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60 (475 60)

Lubiprostone Capsules 8 mcg, labeled by AvKARE. The label states 60 capsules per container and includes instructions to swallow whole without breaking or chewing. It notes that each soft gel capsule contains 8 mcg of active ingredient and provides storage conditions. The label includes the NDC 42291-475-60 and a barcode.*

FDA Label Image

60 (476 60)

Lubiprostone Capsules 24 mcg by AvKARE in a 60-capsule package. The label instructs to swallow whole without breaking or chewing. It includes storage information advising protection from extreme temperatures and keeping the product in a tightly closed, light-resistant container out of children's reach. The product is prescription only.*

FDA Label Image

Chem Structure (Lubiprostone Capsules 1)

Chemical structure diagram of lubiprostone showing its molecular framework including hydroxyl, carbonyl, fluorine groups, and a carboxylic acid side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.